References
- Lindstorm J. M., Einarson B. L., Lennon V. A., Seybold M. E. Pathological mechanisms in experimental myasthenia gravis. J. Exp. Med. 1976; 114: 726–738
- Neim F., Keesey J. C., Herrmann C., Lindstrom J., Zeller E., Walford R. L. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. Tissue Antigens 1978; 12: 381–386
- Dawkins R. L. Myasthenia gravis. Histocompatibility testing 1980, P. I. Terasaki. UCLA Tissue Typing Laboratory Press, Los Angela 1980; 662–667
- Compson D. A.S., Vincent A., Newsom-Davis J., Batchelor J. R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579–601
- Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojyobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic group, HLA 1991. Oxford Press, Oxford 1992; 1: 1063–1220
- Morita K., Moriuchi J., Inoko H., Tsuji K., Arimori S. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan. Ann. Neurol. 1991; 29: 168–174
- Horiki T., Moriuchi J., Inoko H., Morita K., Tsuji K., Shinohara Y, et al. HLA-DPB1 allele association with earlyonset myasthenia gravis in Japan. Neurology. 1993; 43: 771–774
- Ota M., Seki T., Nomura N., Sugiura K., Mizuki N., Fukushima H, et al. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991; 38: 60–11
- Nomura N., Ota M., Tsuji K., Inoko H. HLA-DQB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1991; 38: 53–59
- Ota M., Seki T., Fukushima H., Tsuji K., Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39: 187–202
- Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
- Svejgaard A., Ryder L. P. HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann. Hum. Genet 1981; 45: 293–298
- Morling N., Friis J., Fugger L., Georgsen J., Heilmann C., Pedersen F. K., et al. DNA polymorphism of HLA class II genes in pauciarticular juvenile rheumatoid arthritis. Tissue Antigens 1991; 38: 16–23
- Svejgaard A., Ryder L. P. HLA and disease associations; Detecting the strongest association. Tissue Antigens 1994; 43: 18–27
- Bell J., Rassenti L., Smoot S., Smith K., Newby C., Hohlfeld R., et al. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1986; 1: 1058–1060
- Kida K., Hayashi M., Yamada I., Matsuda H., Yoshinaga J., Takami S., et al. Heterogeneity in myasthenia gravis: HLA phenotype and autoantibody response in ocular and generalized types. Ann. Neurol. 1987; 21: 274–278
- Ong B., Willcox N., Wordsworth P., Beeson D., Vincent A., Altmann D., et al. Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA 1991; 88: 7343–7347
- Hoffman R. W., Shaw S., Francis L. C., Larson M. G., Petersen R. A., Chylack L. T., et al. HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis. Arthritis Rhum 1986; 29: 1057–1062
- Dong R. P., Kimura A., Okubo R., Shinagawa H., Tamai H., Nishimura Y., et al. HLA-A and DPBl loci confer susceptibility to Graves' disease. Human Immunol. 1992; 35: 165–172